BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Treatment
712 results:

  • 1. Mobocertinib: Mechanism of action, clinical, and translational science.
    Hanley MJ; Camidge DR; Fram RJ; Gupta N
    Clin Transl Sci; 2024 Mar; 17(3):e13766. PubMed ID: 38511563
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical diagnosis and treatment of 14 cases of scar cancer ulcer wound on head and face].
    Chen X; Huang G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Mar; 38(3):342-347. PubMed ID: 38500429
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nanobody-mediated targeting of zinc phthalocyanine with polymer micelles as nanocarriers.
    Mesquita B; Singh A; Prats Masdeu C; Lokhorst N; Hebels ER; van Steenbergen M; Mastrobattista E; Heger M; van Nostrum CF; Oliveira S
    Int J Pharm; 2024 Apr; 655():124004. PubMed ID: 38492899
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Febrile Ulceronecrotic Mucha-Habermann Disease Associated With Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature.
    Chen C; Fahmy LM; Schreidah CM; Magro CM; Geskin LJ
    Am J Dermatopathol; 2024 Apr; 46(4):238-242. PubMed ID: 38457671
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
    Bai X; Li S; Luo Y
    Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Disease-Specific Mortality of Dermatofibrosarcoma Protuberans After Mohs Surgery Versus Wide Local Excision: A Systematic Review and meta-Analysis.
    Crum OM; O'Hern K; Demer AM; Brewer JD
    Dermatol Surg; 2024 Apr; 50(4):317-321. PubMed ID: 38335454
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous cancers.
    Schenk KM; Deutsch JS; Chandra S; Davar D; Eroglu Z; Khushalani NI; Luke JJ; Ott PA; Sosman JA; Aggarwal V; Schollenberger MD; Sharfman WH; Bibee KP; Scott JF; Loss MJ; Wang H; Qi H; Sharon E; Streicher H; Chen HX; Woodward RN; Bagnasco SM; Taube JM; Topalian SL; Brennan DC; Lipson EJ
    J Clin Oncol; 2024 Mar; 42(9):1011-1020. PubMed ID: 38252910
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Disparities in the Receipt of Systemic treatment in metastatic Melanoma.
    Kakish H; Pawar O; Bhatty M; Doh S; Mulligan KM; Rothermel LD; Bordeaux JS; Mangla A; Hoehn RS
    Am J Clin Oncol; 2024 May; 47(5):239-245. PubMed ID: 38251734
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and meta-Analysis.
    Tosti G; Pepe F; Gnagnarella P; Silvestri F; Gaeta A; Queirolo P; Gandini S
    Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201930
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Amelioration of Acute Radiation Dermatitis in Breast cancer Patients by a Bioadhesive Barrier-Forming Gel (Episil): A Single-Center, Open, Parallel, Randomized, Phase I/II Controlled Trial.
    Li Q; Feng S; Yu Z; Wang Y; Tian L; Geng H; Guo C; Ning F; Luo J; Liu C
    Clin Pharmacol Ther; 2024 May; 115(5):1085-1091. PubMed ID: 38159264
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Outcomes of Head and Neck Microvascular Free Tissue Transfer for Advanced Cutaneous Squamous Cell Carcinoma: A Comparison of Solid Organ Transplant Recipients to Nontransplant Patients.
    Wang RY; Gallagher KK; Hernandez DJ; Sandulache VC; Sturgis EM; Huang AT
    J Oral Maxillofac Surg; 2024 Mar; 82(3):347-355. PubMed ID: 38103578
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma.
    Dunsche L; Ivanisenko N; Riemann S; Schindler S; Beissert S; Angeli C; Kreis S; Tavassoli M; Lavrik I; Kulms D
    Cell Death Dis; 2023 Dec; 14(12):831. PubMed ID: 38097548
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Medication-Related Osteonecrosis of the Jaw: A Cross-Sectional Study on the Prevalence of Cutaneous Manifestations and the Primary Care Physician's Role in its Early Diagnosis.
    Whitefield S; Ilan MB; Lazarovici TS; Friedlander-Barenboim S; Kassem R; Yarom N
    Am J Med; 2024 Mar; 137(3):266-272. PubMed ID: 38042241
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Simultaneous Determination of Prednisone and Prednisolone in Serum by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry.
    Schofield RC; Scordo M; Shah G; Carlow DC
    Methods Mol Biol; 2024; 2737():413-422. PubMed ID: 38036842
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. INDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events.
    Deutsch A; Lacouture M; Andriessen A; Choi JN; Ho AY; McLellan BN; Mitchell E; Leventhal JS
    J Drugs Dermatol; 2023 Nov; 22(11):SF389716s3-SF389716s10. PubMed ID: 37943279
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Surgery or Not? A Systematic Review of Facial Congenital Melanocytic Nevi treatment Patterns and Outcomes.
    Ibelli TJ; Bauer B; Kleinman EP; Kuruvilla A; Mendiratta D; Scope A; Seyidova N; Taub PJ
    Ann Plast Surg; 2024 Jan; 92(1):120-132. PubMed ID: 37856246
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Depigmentation of Melanin-containing Tissues Using Hypochlorous Acid to Enhance Hematoxylin-eosin and Immunohistochemical Staining.
    Wang L; Wang G
    Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):53-59. PubMed ID: 37855438
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Does compartmental resection really impact retroperitoneal soft tissue sarcomas? A retrospective analysis from a Single Referral Center.
    Garcia-Ortega DY; Ortega Jiménez JA; Melendez-Fernandez AP; Álvarez-Cano A; Caro-Sanchez CHS; Vargas-Lara AK; Luna-Ortiz K
    Surg Oncol; 2023 Dec; 51():101997. PubMed ID: 37832278
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Local therapy in advanced melanoma after immune checkpoint inhibitors aiming to achieve complete response.
    de Barros E Silva MJ; Teixeira MR; Lobo MM; Molina AS; Bertolli E; Santos Filho IDAO; Castro Ribeiro HS; Pelizon ACA; Lopes Pinto CA; Duprat Neto JP
    J Cancer Res Ther; 2023; 19(5):1272-1278. PubMed ID: 37787295
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial.
    Grassi E; Zingaretti C; Petracci E; Corbelli J; Papiani G; Banchelli I; Valli I; Frassineti GL; Passardi A; Di Bartolomeo M; Pietrantonio F; Gelsomino F; Carandina I; Banzi M; Martella L; Bonetti AV; Boccaccino A; Molinari C; Marisi G; Ugolini G; Nanni O; Tamberi S
    ESMO Open; 2023 Oct; 8(5):101824. PubMed ID: 37774508
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 36.